Key result
This review highlights neurobiological systems, including corticotropin releasing factor and cytokines, that contribute to the pathophysiology of depression-cardiovascular disease comorbidity.
Understanding the neurobiological adaptations associated with diverse coping strategies may reveal biomarkers or targets impacting stress susceptibility and the comorbidity of depression and cardiovascular disease.
No immediate clinical implications for depression-CVD comorbidity; leaves open CRF and cytokine targets for prospective validation.
Stress initiates a cascade of complex neural and peripheral changes that promote healthy adaption to stress, but when unabated, leads to pathology. Fascinating individual differences arise in the ability to cope with a stressor, rendering an individual more or less likely to develop stress-induced pathologies such as depression, anxiety, and cardiovascular disease. In this review we evaluate recent findings that investigate the neural underpinnings of adopting a passive or active coping response during social defeat stress. Because passive coping is associated with vulnerability to stress-related pathologies and active coping confers resiliency, understanding neurobiological adaptations associated with these diverse coping strategies may reveal biomarkers or targets impacting stress susceptibility. The co-occurrence of stress-induced depression and cardiovascular disease is becoming increasingly clear. Therefore this review focuses on the central mechanisms capable of contributing to psychopathology and cardiovascular disease such as corticotropin releasing factor, neuropeptide Y, monoamines, cytokines and oxidative stress. The impetus for this review is to highlight neurobiological systems that warrant further evaluation for their contribution to the pathophysiology of depression-cardiovascular disease comorbidity.
No takes yet. Share an insight, caveat, or question.
Susan Wood (2014) conducted a review in Depression-Cardiovascular Disease Comorbidity. Social stress and coping responses was evaluated. This review highlights neurobiological systems, including corticotropin releasing factor and cytokines, that contribute to the pathophysiology of depression-cardiovascular disease comorbidity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: